• 1. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

Dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate (CAS No. 83935-54-0): A Comprehensive Overview

Dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate, a compound with the chemical identifier CAS No. 83935-54-0, has garnered significant attention in the field of chemical and pharmaceutical research due to its unique structural and functional properties. This compound, characterized by its nitro and ester functional groups, presents a promising candidate for various applications in drug development and synthetic chemistry.

The molecular structure of Dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate consists of a heptane backbone modified with a nitro group at the fourth carbon and ester groups at the first and seventh carbons. The presence of the 3-methoxy-3-oxopropyl side chain adds complexity to its reactivity, making it a versatile intermediate in organic synthesis. This structural arrangement not only influences its chemical behavior but also opens up possibilities for its use in designing novel therapeutic agents.

In recent years, there has been a growing interest in exploring the pharmacological potential of nitro-containing compounds. The nitro group in Dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate can undergo reduction to form an amine, which is a common strategy in medicinal chemistry for enhancing bioavailability and metabolic stability. This transformation makes the compound a valuable building block for synthesizing bioactive molecules.

One of the most compelling aspects of this compound is its role in the development of anti-inflammatory and anti-tumor agents. The nitro group's ability to participate in redox reactions suggests that it could be exploited to develop prodrugs that release active therapeutic agents in response to specific biological conditions. Such prodrug strategies are particularly relevant in oncology, where targeted drug delivery systems can improve treatment efficacy while minimizing side effects.

The ester functionality in Dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate also contributes to its versatility as a synthetic intermediate. Ester groups are commonly used in peptide mimetics and other peptidomimetic drugs due to their stability and ease of modification. By incorporating this compound into synthetic pathways, researchers can access novel derivatives with enhanced pharmacokinetic properties.

Recent studies have highlighted the importance of understanding the stereochemistry of nitro compounds in drug design. The specific arrangement of atoms in Dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate influences its interaction with biological targets, making stereochemical control a critical factor in optimizing its therapeutic potential. Advanced computational methods, such as molecular modeling and quantum mechanics simulations, are being employed to predict and refine the stereochemical outcomes of reactions involving this compound.

The synthesis of Dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate involves multi-step organic transformations, including nitration, esterification, and protection-deprotection strategies. These synthetic routes require careful optimization to ensure high yields and purity. Recent advancements in catalytic methods have enabled more efficient and environmentally friendly synthetic pathways, aligning with the growing emphasis on green chemistry principles.

In conclusion, Dimethyl 4-(3-methoxy-3-oxopropyl)-4-nitroheptanedioate represents a fascinating compound with diverse applications in pharmaceutical research. Its unique structural features, including the presence of nitro and ester groups, make it a valuable intermediate for developing novel therapeutic agents. As research continues to uncover new ways to harness its potential, this compound is poised to play a significant role in future drug discovery efforts.

• 16507-02-1(Methyl 4-methyl-4-nitropentanoate)
• 136587-00-3(Di-tert-Butyl-4-nitro-4-(2-Boc ethyl)heptanedioate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)